Title : Integrated molecular profiling of juvenile myelomonocytic leukemia.

Pub. Date : 2018 Apr 5

PMID : 29437595






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Crizotinib, an ALK/ROS1 inhibitor, markedly suppressed ALK/ROS1 fusion-positive JMML cell proliferation in vitro. Crizotinib ROS proto-oncogene 1, receptor tyrosine kinase Homo sapiens
2 Crizotinib, an ALK/ROS1 inhibitor, markedly suppressed ALK/ROS1 fusion-positive JMML cell proliferation in vitro. Crizotinib ROS proto-oncogene 1, receptor tyrosine kinase Homo sapiens
3 Crizotinib is a promising candidate drug for the treatment of JMML, particularly in patients with ALK/ROS1 fusions. Crizotinib ROS proto-oncogene 1, receptor tyrosine kinase Homo sapiens